Document:

astra_ex1012.htm

EXHIBIT 10.12
  
 THE SECURITIES REPRESENTED BY THIS DOCUMENT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE "ACT"), OR THE SECURITIES LAWS OF ANY STATE OR OTHER COUNTRY, AND MAY NOT BE OFFERED, SOLD TRANSFERRED, PLEDGED, HYPOTHECATED OR OTHERWISE DISPOSED OF EXCEPT PURSUANT TO (i) AN EFFECTIVE REGISTRATION STATEMENT UNDER THE ACT AND ANY APPLICABLE STATE LAWS, (ii) TO THE EXTENT APPLICABLE, RULE 144 UNDER THE ACT (OR ANY SIMILAR RULE UNDER THE ACT RELATING TO THE DISPOSITION OF SECURITIES), OR (iii) AN OPINION OF COUNSEL, IF SUCH OPINION SHALL BE REASONABLY SATISFACTORY TO COUNSEL TO THE ISSUER, THAT AN EXEMPTION FROM REGISTRATION UNDER THE ACT AND APPLICABLE STATE LAW IS AVAILABLE.
  
 ASTRA ENERGY, INC.
 CONVERTIBLE DEBENTURE
 No.  
  
 	 Total Principal Amount: $ 
	  
	 DATE

  
 FOR VALUE RECEIVED, the undersigned, COMPANY NAME., a Nevada corporation (the "Company"), hereby promises to pay to the order of ___________, an individual, or assigns (the "Holder"), in lawful money of the United States of America, and in immediately payable funds, the principal sum of twenty thousand dollars ($20,000), with interest thereon, both before and after default until paid, at the rate of eight percent (8%) per annum, upon the terms and conditions set forth herein. 
  
 1. MATURITY DATE/INTEREST PAYMENTS.  The Company shall pay to the Holder quarterly interest payments in cash with the first payment due on DATE.  Upon conversion of this Debenture as allowed in this Agreement, all accumulated but unpaid interest shall be extinguished.  This Debenture shall mature and all principal and accrued interest shall be fully due and payable by the Company to Holder on  DATE  (the “Maturity Date”). Interest shall be computed on the actual days in a year and the actual number of days elapsed.  
  
 2. CONVERTIBILITY.  This Debenture may be converted by the Holder at any time beginning upon execution of this Debenture and ending upon the Maturity Date at a conversion rate of one (1) share of Company Common Stock (the "Shares") per fifty cents  ($0.50 ) principal amount of this Debenture.   No accrued interest will be paid upon conversion.  The Shares to be issued upon conversion shall not be subject to any liens, security interests, pledges, encumbrances, charges, restrictions, demands or claims of any other party whatsoever.  Company shall use its best efforts to expeditiously file with and have declared effective by the Securities and Exchange Commission a registration statement in an appropriate form to register the Shares issuable upon conversion of this Debenture to ensure that Company will have freely tradable stock available to Holder in the event Holder elects to convert this Debenture to Shares.  After conversion, Holder herein agrees not to sell in excess of 50,000 Shares, on a non-cumulative basis, during any calendar month through brokerage transactions.
  
 	 
	1
	

	 

  
 3. PREPAYMENT.  The Company may prepay this Debenture prior to the Maturity Date and prior to the receipt of a conversion election, in whole or in part, at any time. 
  
 4. TRANSFERABILITY.  This Debenture shall be freely transferable by the Holder provided such transfer is in compliance with applicable federal and state securities laws.
  
 5. TERMINATION.  Holder may terminate funding this Debenture immediately upon the occurrence of any of the following events:
    
 a. Bankruptcy or insolvency of the Company;
  
 b. Serious violations (SEC, Reporting, or other) that would adversely affect the Company's publicly traded stock; or
  
 c. A prohibition against selling Company  product(s) in the United States.
  
 6. DEFAULT.  In the event of the Company's failure to pay the principal and interest due hereunder within ten (10) days following the Maturity Date, Holder shall have the option, by written notice to the Company, to declare the unpaid principal amount due to Holder, together with all accrued interest thereon, immediately due and payable. In the event Company fails to cure the default within twenty (20) days of the date of receipt of the written notice by Holder, Holder may pursue any legal remedy available to Holder.  
  
 7. NOTICES.  Notices to be given hereunder shall be in writing and shall be deemed to have been sufficiently given if delivered personally or sent by overnight courier or messenger or sent by registered or certified mail (air mail if overseas), return receipt requested, or by telex, facsimile transmission, telegram or similar means of communication.  Notice shall be deemed to have been received on the date of personal delivery, telex, facsimile transmission, telegram or similar means of communication, or if sent by overnight courier or messenger, shall be deemed to have been received on the next delivery day after deposit with the courier or messenger, or if sent by certified or registered mail, return receipt requested, shall be deemed to have been received on the fifth business day after the date of mailing.  The Parties shall give written notice of any change of address to each other.
  
 8. INVESTOR STATUS.  By providing the principal amount(s) set forth in this Debenture, Holder acknowledges and certifies that this Debenture represents a highly speculative investment and that Holder's personal financial situation is such that (i) Holder can afford to hold  the Debenture for an indefinite period of time and to sustain a complete loss of this investment, and (ii) Holder has adequate means of providing for Holder's current needs and possible contingencies and has no need for liquidity in this investment in the Company.  By virtue of Holder's knowledge and experience in financial and business matters, Holder is capable of evaluating the merits and risks of an investment in the securities.
  
 Holder, if a corporation, partnership, trust or other form of business entity, (i) is authorized and otherwise duly qualified to purchase and hold the Debenture, (ii) has obtained such additional tax and other advice that it has deemed necessary, and (iii) has not been formed for the specific purpose of acquiring the Debenture.
  
 	 
	2
	

	 

  
 Holder consents to the affixing by the Company of such legends on certificates representing the securities as any applicable federal or state securities law may require from time to time.  Holder further acknowledges and certifies that in evaluating the suitability of an investment in the Company, Holder has relied on Holder's own independent investigations and has not relied upon any representations or other information (whether oral or written) from the Company, and its officers, directors, agents, employees or representatives.  Holder acknowledges that in making the decision to invest in the Company, Holder has, prior to any purchase of the securities, been given the information on the Company, its business, and its financials, had access and opportunity to examine this offer, and had an opportunity to ask questions of, and to receive answers from, the Company or any person acting on its behalf concerning the terms and conditions of this offering.  Holder has been furnished with access to all publicly available materials relating to the business, finances, and operations of the Company and material relating to the offer and sale of the securities, which have been requested.  Holder has received complete and satisfactory answers to any such inquiries.  Holder acknowledges that Holder has not received any formal disclosure document regarding this investment, and Holder is an accredited investor as defined in Rule 501 of Regulation D of the Securities Act of 1933, as amended.
  
 9. GOVERNING LAW.  This Debenture shall be governed by and construed and interpreted in accordance with the laws of the state of Nevada applicable to contracts made and to be performed entirely therein, without giving effect to the rules and conflicts of law.
  
 10. ATTORNEYS FEES.  In the event of default by the Company requiring the Holder or any assignee thereof to refer this Debenture to an attorney for collection, the Company agrees to pay all reasonable costs and expenses incurred in attempting or effecting collection hereunder, including reasonable attorney's fees, whether or not suit is instituted.
  
 11. MODIFICATION.  This Debenture may be modified or amended only by an agreement in writing signed by the party against whom the agreement is sought to be enforced.
  
 12. CONFORMITY WITH LAW. All agreements between the Company and Holder are expressly limited, so that in no event or contingency whatsoever, whether by reason of the advancement of the proceeds of this Debenture, acceleration of maturity of the unpaid principal balance, or otherwise, shall the amount paid or agreed to be paid to Holder of this Debenture for the use, forbearance, or detention of the money to be advanced under this Debenture exceed the highest lawful rate permissible under applicable usury laws.  If, under any circumstances whatsoever, fulfillment of any provision of this Debenture or any other agreement pertaining hereto, after timely performance of such provision is due, shall involve transcending the limit of validity prescribed by law which a court of competent jurisdiction deems applicable, then, ipso facto, the obligations to be fulfilled shall be reduced to the limit of such validity, and if, under any circumstances whatsoever, Holder shall ever receive as interest an amount that exceeds the highest lawful rate, the amount that would be excessive interest shall be applied to the reduction of the unpaid principal balance under this Debenture and not to the payment of interest, or, if such excessive interest exceeds the unpaid balance of principal under this Debenture, such excess shall be refunded to Company.  This provision shall control every other provision of all agreements between Company and Holder.
  
 	 
	3
	

	 

  
 IN WITNESS WHEREOF, the Company and Holder have executed this Debenture as of 
  
 DATE.
  
 	 	 The Company
	
	  
	  
	  

	  
	 NAME
	  

	  
	 a Nevada corporation
	  

	 	 	 	 
		BY:  		
	  
	 ITS:  
	 President
	 
	 	 		 
	 	The Holder	 
	  
	  
	  

	  
	  
	  

   
 	 
	4EX-10.1

 Exhibit 10.1 

TRANSITION AND SEPARATION AGREEMENT 

March 2, 2022 
 VIA EMAIL

 Dear Cheng: 
 This
letter (the “Agreement”) confirms the agreement between you and TuSimple Holdings Inc. (the “Company”) regarding the termination of your employment with the Company. 

1. Termination Date and Resignation as Officer and Director. Your employment with the Company will terminate on March 3, 2022 (the
“Termination Date”). By signing this Agreement, you hereby resign as the President and Chief Executive Officer with the Company and as member of the Company’s Board of Directors (including any committees thereof), in each case
effective as of the Termination Date. You further agree to execute a separate letter of resignation, in a form prescribed by the Company and substantially similar to the form previously shared with you, on or prior to the Termination Date. 

2. Salary and Vacation Pay. On the Termination Date, the Company will pay you $50,000, less all applicable withholdings. This amount
represents all of your salary earned through the Termination Date and all of your accrued but unused vacation time or PTO. You acknowledge that, prior to the execution of this Agreement, you were not entitled to receive any additional money from the
Company and that the only payments and benefits that you are entitled to receive from the Company in the future are those specified in this Agreement. 

3. COBRA Premiums. You will receive information about your right to continue your group health insurance coverage under the Consolidated
Omnibus Budget Reconciliation Act (“COBRA”) after the Termination Date. In order to continue your coverage, you must file the required election form. 

4. Severance Benefits & Transition Services. 

a. Transition Services and Severance Pay. You will transition to a new role as a Consultant where you agree to be
available to perform limited transition services (“Transition Services”) for one year following your Termination Date as set forth in Exhibit A attached hereto (the “Consulting Agreement”). 

b. COBRA Premiums. If you elect to continue group health insurance coverage, the Company will pay the employer portion
of the monthly premium under COBRA for you and, if applicable, for your dependents until the earliest of (a) the end of the period of 18 months following the month in which the Termination Date occurs, (b) the expiration of your
continuation coverage under COBRA or (c) the date when you become eligible for substantially equivalent health insurance in connection with new employment or self-employment; provided, that, if necessary to avoid adverse tax consequences
(including, without limitation, in order to 

 Cheng Lu 

March 2, 2022 
  Page
 2
 
  

 
comply with the Patient Protection and Affordable Care Act and any rules or regulations issued thereunder), the Company may elect to (x) provide for the modification or substitution of such
benefit, or (y) treat such monthly premium payments as taxable compensation income to you. You agree to immediately notify the Company when you become eligible for substantially equivalent health insurance in connection with new employment or
self-employment. 
 c. Acknowledgement. You acknowledge that these Severance Benefits are additional payments to you,
at least some of which you are not otherwise entitled to, and are expressly made in exchange for your acceptance of the terms set forth in this Agreement. 

5. Options. During your employment with the Company and prior to the date hereof, the Company granted you, from time to time, certain
options to purchase such number of shares of its Class A Common Stock as set forth in Exhibit B attached hereto (the “Time Based Options”) pursuant to certain notice of stock options and stock option agreements (each notice and
agreement, a “Stock Option Agreement”). If you sign this Agreement and it becomes effective, the Time Based Options shall continue to vest on the current vesting schedule for the twelve-month period following the Termination Date, subject
to your continuous service and, if you remain in continuous service through the twelve-month anniversary of the Termination Date, then all of the shares subject to the Time Based Options shall become vested and exercisable on such twelve-month
anniversary, regardless of whether the applicable time-based vesting requirements have been satisfied as of such date, provided that if your continuous service with the Company is terminated by the Company for any reason (other than Cause by the
Company as such term is defined in the Plan), the Time Based Options shall immediately become vested in full. In addition, if you sign this Agreement and it becomes effective, then notwithstanding anything to the contrary in the applicable Stock
Option Agreements, each of the Time Based Options shall remain outstanding and exercisable until the earlier of: (x) the date on which any of the Company’s outstanding options are terminated in connection with the occurrence of certain
corporate transactions, as described in the applicable stock plan; (y) the original expiration date applicable to such Time Based Option; and (z) the second (2nd) anniversary of the date on which your Transition Services with the Company
are terminated, and, to the extent not exercised in the applicable permitted time, the Time Based Options will expire. In connection with the foregoing, you hereby agree and acknowledge that to the extent that any of the Time Based Options were
intended to qualify as “incentive stock options” within the meaning of Section 422(b) of the Internal Revenue Code of 1986, as amended (the “Code”), they will case to do so as of the date this Agreement becomes effective and
they will be treated as non-statutory stock options and all applicable federal and state income and employment withholding taxes will apply in connection with the exercise of the options. Further, if you sign
this Agreement and it becomes effective, you may transfer the Time Based Options to an immediate family member or family-related trusts through a gift pursuant to a form prescribed by the Company, pursuant to which such transferee will agree to be
bound by the same terms and conditions of the Stock Option Agreement as if the transferee were a party thereto. In all other respects, all Stock Option Agreements between you and the Company with respect to the Time Based Options will remain in full
force and effect, and you agree to remain bound by such Stock Option Agreements. The Company also granted you an option to purchase 1,150,000 shares of its Class A Common Stock on March 4, 2021 (the “Milestone Option”). You
further acknowledge and agree that none of the shares subject to the Milestone Option will have become vested as of the Termination Date and that such Milestone Option shall terminate completely as of the Termination Date. 

  
 2 

 Cheng Lu 

March 2, 2022 
  Page
 3
 
  

 6. RSU Vesting Acceleration. On December 24, 2020, the Company granted you
1,000,000 restricted stock units (the “RSUs”), pursuant to a notice of restricted stock unit award and restricted stock unit agreement (collectively, the “Restricted Stock Unit Agreement”). If you sign this Agreement and it
becomes effective, you will become vested in all unvested RSUs, regardless whether the applicable time-based vesting requirement has been satisfied as of the Termination Date, effective as of the date immediately prior to the Termination Date.
Notwithstanding anything on the contrary in the Restricted Stock Unit Agreement, the settlement of the RSUs that become vested in accordance with the above shall occur no later than March 15, 2023. In all other respects, the Restricted Stock
Unit Agreement will remain in full force and effect, and you agree to remain bound by that Restricted Stock Unit Agreement. 
 7. Release
of All Claims. In consideration for receiving the severance benefits described above, to the fullest extent permitted by law, you waive, release and promise never to assert any claims or causes of action, whether or not now known, against the
Company or its predecessors, successors or past or present subsidiaries, stockholders, directors, officers, employees, consultants, attorneys, agents, assigns and employee benefit plans with respect to any matter, including (without limitation) any
matter related to your employment with the Company or the termination of that employment, including (without limitation) claims to attorneys’ fees or costs, claims of wrongful discharge, constructive discharge, emotional distress, defamation,
invasion of privacy, fraud, breach of contract or breach of the covenant of good faith and fair dealing and any claims of discrimination or harassment based on sex, age, race, national origin, disability or any other basis under Title VII of the
Civil Rights Act of 1964, the California Fair Employment and Housing Act, the California Fair Pay Act, the Equal Pay Act, the Age Discrimination in Employment Act of 1967, the Americans with Disabilities Act, the National Labor Relations Act, the
Family and Medical Leave Act, the Employee Retirement Income Security Act of 1974, as amended (“ERISA”), the Workers Adjustment and Retraining Notification (“WARN”) Act, the California WARN Act, and all other laws and regulations
relating to employment. However, this release covers only those claims that arose prior to the execution of this Agreement. Execution of this Agreement does not bar (i) any claim that arises hereafter, including (without limitation) a claim for
breach of this Agreement, (ii) any claim for coverage under any D&O or other similar insurance policy, or (iii) any claim for indemnification under any written agreement with the Company, Company
by-laws or applicable law. You understand that this Agreement does not limit your ability to file a charge or complaint with the Equal Employment Opportunity Commission, the Securities and Exchange Commission
or any other federal, state or local governmental agency or commission (each, a “Government Agency”). You further understand that this Agreement does not limit your ability to communicate with, or otherwise participate in any investigation
or proceeding that may be conducted by, a Government Agency. However, to the fullest extent permitted by law, you agree that you are waiving the right to monetary damages or other equitable or monetary relief as a result of any such charge,
complaint, investigation or proceeding. 

  
 3 

 Cheng Lu 

March 2, 2022 
  Page
 4
 
  

 8. Waiver. You expressly waive and release any and all rights and benefits under
Section 1542 of the California Civil Code (or any analogous law of any other state), which reads as follows: 
 A
general release does not extend to claims that the creditor or releasing party does not know or suspect to exist in his or her favor at the time of executing the release and that, if known by him or her, would have materially affected his or her
settlement with the debtor or released party. 
 9. Covenant Not to Sue. To the fullest extent permitted by law, at no time after you
sign this Agreement will you pursue, or cause or knowingly permit the prosecution, in any state, federal or foreign court, or before any local, state, federal or foreign administrative agency, or any other tribunal, of any charge, claim or action of
any kind, nature and character whatsoever, known or unknown, which you may now have, have ever had, or may in the future have against Releasees, which is based in whole or in part on any matter released by this Agreement. If approached by anyone for
counsel or assistance in the presentation or prosecution of any disputes, differences, grievances, claims, charges, or complaints against any of the Releasees, you shall do no more than state that you cannot provide counsel or assistance. Nothing in
this paragraph shall prohibit or impair you or the Company from complying with all applicable laws, nor shall this Agreement be construed to obligate either party to commit (or aid or abet in the commission of) any unlawful act. 

10. Protected Rights: You understand that nothing in the General Release and Waiver of Claims and Covenant Not to Sue paragraphs above,
or otherwise in this Agreement, limits your ability to file a charge or complaint with the Equal Employment Opportunity Commission, the National Labor Relations Board, the Occupational Safety and Health Administration, the Securities and Exchange
Commission or any other federal, state or local government agency or commission (“Government Agencies”). You further understand that this Agreement does not limit your ability to communicate with any Government Agencies or otherwise
participate in any investigation or proceeding that may be conducted by any Government Agency, including providing documents or other information, without notice to the Company. This Agreement does not limit your right to receive an award for
information provided to any Government Agencies. 
 11. No Admission. Nothing contained in this Agreement will constitute or be
treated as an admission by you or the Company of liability, any wrongdoing or any violation of law. 
 12. Proprietary Information:
You hereby acknowledge that you are bound by the Company’s Proprietary Information and Inventions Agreement (the “Confidentiality Agreement”), a copy of which is attached as Exhibit C, and that as a result of your employment with the
Company you have had access to the Company’s Proprietary Information (as defined in the Confidentiality Agreement), that you will hold all such Proprietary Information, in strictest confidence and that you will not make use of such Proprietary
Information on behalf of anyone, except as required in the course of your employment with the Company. 

  
 4 

 Cheng Lu 

March 2, 2022 
  Page
 5
 
  

 13. No Disparagement. You agree that you will never make any negative or disparaging
statements (orally or in writing) about the Company or its stockholders, directors, officers, employees, products, services or business practices, except as required by law. 

14. Severability. If any term of this Agreement is held to be invalid, void or unenforceable, the remainder of this Agreement will
remain in full force and effect and will in no way be affected, and the parties will use their best efforts to find an alternate way to achieve the same result. 

15. Taxes. 

a. Withholding. All forms of compensation referred to in this Agreement are subject to reduction to reflect applicable
withholding and payroll taxes and other deductions required by law. 
 b. Section 409A. Payments under this Agreement
are intended to be exempt from, or comply with, Section 409A of the Code, and this Agreement will be interpreted to achieve this result. Without limiting the foregoing, the parties intend that, to the maximum extent possible, any severance or
post-service type payment shall qualify as a short-term deferral pursuant to Treasury Regulation § 1.409A-1(b)(4) or a separation payment pursuant to Treasury Regulation § 1.409A-1(b)(9). 
 c. General. You hereby acknowledge and agree that the Company nor
any of its subsidiaries or affiliates has or had any duty to design your compensation, severance rights, equity awards or the settlement of such awards in a manner that minimizes your tax liabilities and you will not make any claim against the
Company nor any of its subsidiaries or affiliates, or any of their respective officers, employees, directors, agents, advisors or boards of directors with respect to the tax liabilities and withholding obligations related thereto. You further
acknowledge and agree that in no event will the Company reimburse you for any taxes that may be imposed as a result of Section 409A of the Code (or under any similar state law) and you hereby further expressly agree to fully indemnify and hold
harmless the Company, its subsidiaries and affiliates for any tax consequences, including interest and penalties, with respect thereto. 

16. Choice of Law. This Agreement will be construed and interpreted in accordance with the laws of the State of Delaware (other than its
choice-of-law provisions). 
 17. Review of Agreement;
Expiration of Offer: This Agreement will become effective on the later of your Termination Date or the date that it has been signed by both you and the Company. By signing below, you affirm that you were advised to consult with an attorney of
your own choice prior to signing this Agreement. The Company will reimburse you for any legal fees incurred in connection with the review, negotiation and preparation of this Agreement up to $10,000. 

18. Modification; Counterparts; Electronic/PDF Signatures: It is expressly agreed that this Agreement may not be altered, amended,
modified, or otherwise changed in any respect except by another written agreement that specifically refers to this Agreement, executed by 

  
 5 

 Cheng Lu 

March 2, 2022 
  Page
 6
 
  

 
authorized representatives of each of the parties to this Agreement. This Agreement may be executed in any number of counterparts, each of which shall constitute an original and all of which
together shall constitute one and the same instrument. Counterparts may be delivered via facsimile, electronic mail (including pdf or any electronic signature complying with the U.S. federal ESIGN Act of 2000, e.g., www.docusign.com) or other
transmission method and any counterpart so delivered shall be deemed to have been duly and validly delivered and be valid and effective for all purposes. 

Please indicate your agreement with the above terms by signing below. 

 

			
	 Very truly yours,

	
	 TuSimple Holdings Inc.

		
	 By:
	 	 /s/ Mo Chen

	 Name: Mo Chen

	 Title: Executive Chairman

 I agree to the terms of this Agreement, and I am voluntarily signing this release of all
claims. I acknowledge that I have read and understand this Agreement, and I understand that I cannot pursue any of the claims and rights that I have waived in this Agreement at any time in the future. 

 

	
	 /s/ Cheng Lu

	 Signature of Cheng Lu

 Dated: March 2,
2022                 

  
 6 

 EXHIBIT A 

CONSULTING AGREEMENT 

  

 EXHIBIT B 

OPTIONS 
  

									
	 Grant Date
	  	 No. of Shares
	  	 Vesting

Commencement Date
	  	 Vesting Schedule
	  	 Exercise

Price

	 12/24/2020
	  	 500,000
	  	 12/31/2020
	  	 3-year vesting schedule, 30% of the total shares vest on the first year
anniversary date of the optionee’s continuous service with the Company after the Vesting Commencement Date, and an additional 8.75% of total shares vest for each quarter of continuous service thereafter.
	  	 $4.20

					
	 12/24/2020
	  	 100,000
	  	 12/31/2020
	  	 3-year vesting schedule, 30% of the total shares vest on the first year
anniversary date of the optionee’s continuous service with the Company after the Vesting Commencement Date, and an additional 8.75% of total shares vest for each quarter of continuous service thereafter.
	  	 $8.11

					
	 12/24/2020
	  	 100,000
	  	 12/31/2020
	  	 3-year vesting schedule, 30% of the total shares vest on the first year
anniversary date of the optionee’s continuous service with the Company after the Vesting Commencement Date, and an additional 8.75% of total shares vest for each quarter of continuous service thereafter.
	  	 $14.00

					
	 3/4/2021
	  	 1,150,000
	  	 12/31/2020
	  	 5-year vesting schedule, with 5% of the total shares vesting after each quarter
of continuous service after the Vesting Commencement Date.
	  	 $14.1401

  

 EXHIBIT C 

PROPRIETARY INFORMATION AND INVENTIONS AGREEMENT

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00341-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00341-of-00352.parquet"}]]